Peptide Therapy in Johnson City at Peak Performance Wellness The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics CagriSema Demonstrates Significant Weight Loss at 68 Weeks Drug Topics Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond Metabolism Clinical and Experimental Starting dose of Cagrilintide : r Peptidesource Peptide side effects no one talks about BPC 157 headaches. TB 500 fatigue. CJC Ipamorelin water retention. Most people quit. But 90% of the time it's the protocol, not the peptide.